inlyta
pfizer europe ma eeig - axitinib - carcinom, nyrecelle - protein kinase hæmmere - inlyta is indicated for the treatment of adult patients with advanced renal cell carcinoma (rcc) after failure of prior treatment with sunitinib or a cytokine.
axitinib "stada" 1 mg filmovertrukne tabletter
stada arzneimittel ag - axitinib - filmovertrukne tabletter - 1 mg
axitinib "stada" 3 mg filmovertrukne tabletter
stada arzneimittel ag - axitinib - filmovertrukne tabletter - 3 mg
axitinib "stada" 5 mg filmovertrukne tabletter
stada arzneimittel ag - axitinib - filmovertrukne tabletter - 5 mg
axitinib "stada" 7 mg filmovertrukne tabletter
stada arzneimittel ag - axitinib - filmovertrukne tabletter - 7 mg